dipyridamole and Cardiomyopathy, Chagas
dipyridamole has been researched along with Cardiomyopathy, Chagas in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Dipyridamole (DPY) is an alternative to counteract the pathophysiological phenomena involved in Chagas cardiomyopathy." | 3.85 | Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis. ( Alvarez, C; Bonfante-Cabarcas, R; Bonfante-Rodríguez, R; Caicedo, P; Giraldo, E; Rodríguez-Bonfante, C; Santeliz, S; Yustiz, MD, 2017) |
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Santeliz, S | 1 |
Caicedo, P | 1 |
Giraldo, E | 1 |
Alvarez, C | 1 |
Yustiz, MD | 1 |
Rodríguez-Bonfante, C | 1 |
Bonfante-Rodríguez, R | 1 |
Bonfante-Cabarcas, R | 1 |
Tanaka, DM | 1 |
de Oliveira, LFL | 1 |
Marin-Neto, JA | 1 |
Romano, MMD | 1 |
de Carvalho, EEV | 1 |
de Barros Filho, ACL | 1 |
Ribeiro, FFF | 1 |
Cabeza, JM | 1 |
Lopes, CD | 1 |
Fabricio, CG | 1 |
Kesper, N | 1 |
Moreira, HT | 1 |
Wichert-Ana, L | 1 |
Schmidt, A | 1 |
Higuchi, ML | 1 |
Cunha-Neto, E | 1 |
Simões, MV | 1 |
Petretta, M | 1 |
Cuocolo, A | 1 |
Kuschnir, E | 1 |
Sgammini, H | 1 |
Castro, R | 1 |
Evequoz, C | 1 |
Ledesma, R | 1 |
Other Studies
4 other studies available for dipyridamole and Cardiomyopathy, Chagas
Article | Year |
---|---|
Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.
Topics: Acute Disease; Animals; Chagas Cardiomyopathy; Dipyridamole; Disease Models, Animal; Drug Synergism; | 2017 |
Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.
Topics: Animals; Chagas Cardiomyopathy; Cricetinae; Dipyridamole; Disease Models, Animal; Echocardiography; | 2019 |
The long way to defeating Chagas cardiomyopathy.
Topics: Cardiomyopathies; Chagas Cardiomyopathy; Chagas Disease; Dipyridamole; Humans | 2019 |
[Chronic Chagas' cardiomyopathy: effects of dipyradamole on ventricular dynamics].
Topics: Adult; Aged; Chagas Cardiomyopathy; Dipyridamole; Female; Heart; Heart Ventricles; Humans; Male; Mid | 1983 |